HomeORKA • NASDAQ
add
Oruka Therapeutics Inc
Previous close
$9.46
Day range
$9.40 - $10.29
Year range
$5.49 - $53.88
Market cap
376.65M USD
Avg Volume
261.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.09M | 265.53% |
Net income | -21.00M | -196.72% |
Net profit margin | — | — |
Earnings per share | -0.40 | — |
EBITDA | -25.07M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 349.09M | 1,158.31% |
Total assets | 377.11M | 1,235.81% |
Total liabilities | 12.39M | -61.72% |
Total equity | 364.72M | — |
Shares outstanding | 41.68M | — |
Price to book | 1.09 | — |
Return on assets | -16.22% | — |
Return on capital | -16.75% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -21.00M | -196.72% |
Cash from operations | -20.87M | -12,322.02% |
Cash from investing | 42.87M | — |
Cash from financing | — | — |
Net change in cash | 22.00M | -20.71% |
Free cash flow | -18.83M | — |
About
Founded
2024
Headquarters
Website
Employees
28
